AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
Log in

NASDAQ:INGNInogen Stock Price, Forecast & News

$36.77
+0.91 (+2.54 %)
(As of 07/2/2020 11:57 AM ET)
Add
Compare
Today's Range
$36.10
Now: $36.77
$37.00
50-Day Range
$32.85
MA: $36.44
$41.23
52-Week Range
$31.21
Now: $36.77
$76.89
Volume32,595 shs
Average Volume324,646 shs
Market Capitalization$810.78 million
P/E Ratio58.37
Dividend YieldN/A
Beta0.79
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.
Read More
Inogen logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.34 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:INGN
CUSIPN/A
Phone805-562-0500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$361.94 million
Cash Flow$1.77 per share
Book Value$15.67 per share

Profitability

Net Income$20.95 million

Miscellaneous

Employees1,020
Market Cap$810.78 million
Next Earnings Date8/5/2020 (Estimated)
OptionableOptionable

Receive INGN News and Ratings via Email

Sign-up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

Inogen (NASDAQ:INGN) Frequently Asked Questions

How has Inogen's stock been impacted by COVID-19 (Coronavirus)?

Inogen's stock was trading at $40.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, INGN stock has decreased by 9.5% and is now trading at $36.77. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Inogen?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Inogen.

When is Inogen's next earnings date?

Inogen is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Inogen.

How were Inogen's earnings last quarter?

Inogen Inc (NASDAQ:INGN) posted its quarterly earnings data on Tuesday, May, 5th. The medical technology company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.04. The medical technology company had revenue of $88.49 million for the quarter, compared to analysts' expectations of $82.33 million. Inogen had a net margin of 3.90% and a return on equity of 4.93%. Inogen's quarterly revenue was down 1.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.24 earnings per share. View Inogen's earnings history.

What price target have analysts set for INGN?

7 analysts have issued 1 year price targets for Inogen's stock. Their forecasts range from $45.00 to $80.00. On average, they expect Inogen's stock price to reach $60.80 in the next year. This suggests a possible upside of 65.4% from the stock's current price. View analysts' price targets for Inogen.

Has Inogen been receiving favorable news coverage?

News headlines about INGN stock have been trending very negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Inogen earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the medical technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Inogen.

Are investors shorting Inogen?

Inogen saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 2,830,000 shares, a drop of 6.0% from the May 31st total of 3,010,000 shares. Based on an average daily volume of 427,500 shares, the days-to-cover ratio is currently 6.6 days. Currently, 15.5% of the shares of the company are short sold. View Inogen's Current Options Chain.

Who are some of Inogen's key competitors?

What other stocks do shareholders of Inogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), Medivation (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), First Solar (FSLR), Netflix (NFLX), Intel (INTC) and Advanced Micro Devices (AMD).

Who are Inogen's key executives?

Inogen's management team includes the following people:
  • Mr. Scott Wilkinson, CEO, Pres & Director (Age 54)
  • Mr. Brenton Taylor, Co-founder & Exec. VP of Engineering (Age 38)
  • Ms. Alison Perry Bauerlein, Co-founder, Exec. VP of Fin., CFO, Corp. Sec. & Treasurer (Age 38)
  • Mr. Bart Sanford, Exec. VP of Operations (Age 53)
  • Mr. Byron Myers, Exec. VP of Sales & Marketing (Age 40)

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

How do I buy shares of Inogen?

Shares of INGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Inogen's stock price today?

One share of INGN stock can currently be purchased for approximately $36.77.

How big of a company is Inogen?

Inogen has a market capitalization of $810.78 million and generates $361.94 million in revenue each year. The medical technology company earns $20.95 million in net income (profit) each year or $1.07 on an earnings per share basis. Inogen employs 1,020 workers across the globe.

What is Inogen's official website?

The official website for Inogen is www.inogen.com.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.